Modifying the gut microbiota can ameliorate hypertensive kidney damage and inflammation

New research in rodents indicates that altering gut microbes may affect the development of organ damage associated with hypertension.

Exscientia ends cancer study as it focuses on other trials of AI-driven drug candidates

AI drug discovery and development company Exscientia is stopping a solid tumor trial as it refocuses its internal pipeline amid plans to ink another partnership

October 4, 2023

Pharmalittle: We’re reading about a GSK vaccine deal, an Alzheimer’s drug approval, and more

Top of the morning to you, and a fine one it is. The skies are clear, the sun is shining, and all sorts of birds

July 3, 2024

MSD’s Keytruda wins expanded FDA combo approval in cervical cancer – Pharmaceutical Technology

Share this article Nearly all cervical cancer cases are linked to infection with high-risk human papillomaviruses (HPV). Image credit: Shutterstock/Naeblys. The US Food and Drug

January 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.